Clinical trial
Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.
NCT01689857 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic surgical scar